NCT06296797 Patient-centered Information on Permanent Contraception
| NCT ID | NCT06296797 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Contraception |
| Study Type | INTERVENTIONAL |
| Enrollment | 650 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 650 participants in total. It began in 2024-04-01 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to understand whether providing information to women with a strong desire to avoid future pregnancy about how tubal sterilization compares to long-acting reversible contraceptives improves perceived access to available contraceptives. Participants will: * Complete a baseline survey * Receive access to web-based educational resources * Complete a brief follow up survey immediately after exploring these web-based resources * Complete a follow-up survey 3 months after enrolling The investigators will compare outcomes among participants provided with access to a new website (intervention) summarizing recent patient-centered outcomes research (PCOR) comparing interval laparoscopic tubal sterilization and long-acting reversible contraception (LARC) to control participants provided with access to the existing Planned Parenthood website on tubal sterilization.
Eligibility Criteria
Inclusion Criteria: * Self-reported fertility * Have a strong desire to avoid future pregnancy * Speak English or Spanish Exclusion Criteria: * Current pregnancy * The inability to speak English or Spanish * Prior tubal sterilization or "Essure" procedure * Menopause * Infertility * Hysterectomy
Contact & Investigator
Eleanor Schwarz, MD, MS
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT06296797 clinical trial?
This trial is open to female participants only, aged 21 Years or older, up to 45 Years, studying Contraception. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06296797 currently recruiting?
Yes, NCT06296797 is actively recruiting participants. Contact the research team at eleanor.schwarz@ucsf.edu for enrollment information.
Where is the NCT06296797 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT06296797 clinical trial?
NCT06296797 is sponsored by University of California, San Francisco. The principal investigator is Eleanor Schwarz, MD, MS at University of California, San Francisco. The trial plans to enroll 650 participants.